USING DEXMEDETOMIDINE FOR THE RELIEF OF PAIN IN THE POSTOPERATIVE PERIOD AFTER SPINAL INJURY

Authors:

Abstract:

Pain syndrome in spinal surgery is an urgent problem far from a final solution. After extensive surgical interventions on the spine, a pronounced postoperative pain syndrome is observed, comparable in intensity to pain after thoracic operations, limb amputations, and extensive interventions on the hip joint. Expansion of knowledge about the pathogenesis of pain formation has led to a revival of interest in the use of drugs such as antidepressants, glucocorticoids, magnesium sulfate, dexmedetomidine for postoperative analgesia. However, data on the effectiveness of their use in spinal trauma surgery are extremely limited. We used dexmedetomidine to optimize perioperative pain management in patients with spinal cord injuries.The study was conducted in the surgical clinic of the AMU. The study included 59 patients who underwent decompression and fixation of the spine at the lumbar and thoracic levels due to spinal cord injury. The patients were divided into 2 groups. In patients of group I, surgical interventions were performed only under general anesthesia, and in group II, dexmedetomidine was included in the general anesthesia regimen. The use of multimodal analgesia protocols, including dexmedetomidine and general anesthesia after decompression of neural structures and fixation of the spine in patients with spinal cord injury, provides adequate pain control throughout the entire postoperative period. In patients operated on for spinal canal stenosis, the use of this scheme does not provide adequate pain control only during the first two hours after surgery.

Keywords:

postoperative spinal injuries dexmedetomidine multimodal analgesia

References:

1. Akeju O, Hobbs LE, Gao L, Burns SM, Pavone KJ, Plummer GS. Dexmedetomidine promotes biomimetic non-rapid eye movement stage 3 sleep in humans: a pilot study. Clin Neurophysiol. (2018) 129:69–78. doi: 10.1016/j.clinph.2017.10.005
2. Algarra NN. Does dexmedetomidine offer brain protection. Minerva Anestesiologica. 2017; 83:1224–1226. doi: 10.23736/S0375-9393.17.12248-0.
3. Farag E. Dexmedetomidine: a multifaceted drug in perioperative medicine. Journal of Clinical Anesthesia.2019; 55:1–2. doi: 10.1016/j.jclinane.2018.12.015.
4. Gao J, Wei L, Xu G, Ren C, Zhang Z, Liu Y. Effects of dexmedetomidine vs sufentanil during percutaneous tracheostomy for traumatic brain injury patients: a prospective randomized controlled trial. Medicine (Baltimore). 2019;98, article e17012 doi: 10.1097/MD.0000000000017012.
5. Jiang L, Hu M, Lu Y, Cao Y, Chang Y, Dai Z. The protective effects of dexmedetomidine on ischemic brain injury: a meta-analysis. Journal of Clinical Anesthesia. 2017; 40:25–32. doi: 10.1016/j.jclinane.2017.04.003.
6. Kaye AD, Chernobylsky DJ, Thakur P, Siddaiah H, Kaye RJ, Eng LK, et al. Dexmedetomidine in enhanced recovery after surgery (ERAS) protocols for postoperative pain. Curr Pain Headache Rep. 2020;24(5):21. https://doi.org/10.1007/s11916-020-00853-z PMID: 32240402.
7. Lee S. Dexmedetomidine: present and future directions. Korean J Anesthesiol. (2019) 72:323–30. doi: 10.4097/kja.19259
8. Lin N, Vutskits L, Bebawy JF, Gelb AW. Perspectives on dexmedetomidine use for neurosurgical patients. Journal of Neurosurgical Anesthesiology. 2019; 31:366–377. doi: 10.1097/ANA.0000000000000554.
9. Liu Y, Liang F, Liu X, Shao X, Jiang N, Gan X. Dexmedetomidine reduces perioperative opioid consumption and postoperative pain intensity in neurosurgery: a meta-analysis. Journal of Neurosurgical Anesthesiology. 2018; 30:146–155. doi: 10.1097/ANA.0000000000000403.
10. Patel M, Onwochei DN, Desai N. Influence of perioperative dexmedetomidine on the incidence of postoperative delirium in adult patients undergoing cardiac surgery. Br J Anaesth. (2022) 129:67–83. doi: 10.1016/j.bja.2021.11.041
11. Sajid B, Mohamed T, Jumaila M. A comparison of oral dexmedetomidine and oral midazolam as premedicants in children. J Anaesthesiol Clin Pharmacol. 2019;35(1):36–40. https://doi.org/10.4103/joacp.JOACP_20_18
12. Song IK, Yi S, Lim HS, et al. A population pharmacokinetic model of intravenous dexmedetomidine for mechanically ventilated children after neurosurgery. Journal of Clinical Medicine . 2019; 8:p. 1563. doi: 10.3390/jcm8101563.
13. Tasbihgou SR, Barends CRM, Absalom AR. The role of dexmedetomidine in neurosurgery. Best Prac Res Clin Anaesthesiol. (2021) 35:221–9. doi: 10.1016/j.bpa.2020.10.002
14. Varsha R, Desai SN, Mudakanagoudar MS, Annigeri VM. Comparison between caudal epidural and ultrasound-guided ilioinguinal-iliohypogastric block with bupivacaine and dexmedetomidine for postoperative analgesia following pediatric inguinal hernia surgeries: a prospective randomized, double-blind study. JAnaesthesiol Clin Pharmacol. (2021) 37:389–94. doi: 10.4103/joacp.JOACP_175_19
15. Wang K, Wu M, Xu J, Wu C, Zhang B, Wang G. Effects of dexmedetomidine on perioperative stress, inflammation, and immune function: systematic review and meta-analysis. Br J Anaesth. (2019) 123:777–94. doi: 10.1016/j.bja.2019.07.027

Publication:

«World of Medicine and Biology» Vol. 19 No. 85 (2023) , с. 97-100
УДК 615.036.8

DOI:

https://doi.org/10.26724/2079-8334-2023-3-85-97-100